Antibiotics

It is produced by the strain of Aspergillus rugulosus. Echinocandin can inhibit (1,3)-β-Glucan synthase, an essential component of the cell wall of susceptible fungi, and has anti-fungal activity against candida.

It is produced by the strain of Streptomyces echinatus. It has the activity of anti-gram-positive bacteria and vaginal trichomonas, and also has the effect on influenza virus and sarcoma 180 cells in vitro.

It is produced by the strain of Streptomyces melanosporofacien. It has the activity of anti-gram-positive bacteria, mycobacterium and protozoa, and can be used as insect repellent and growth promoter for ruminants. Elaiophylin is an autophagy inhibitor, which exerts antitumor activity as a single agent in ovarian cancer cells.

Elsamitrucin is produced by the strain of Actinomycetes J904-21. It has strong anti-tumor activity of mouse tumor cells such as leukemia P388, L1210 and melanoma B16, and its anti-tumor activity is 10-30 times stronger than Chartreusin.

It is produced by the strain of Streptomyces fungicidicus. Enramycin is a polypeptide antibiotic, and it has anti-gram-positive bacteria and mycobacterium activity. Enramycin is composed of two different compounds: Enramycin A and enramycin B.

It is produced by the strain of Streptomyces fungicidicus. It has anti-gram-positive bacteria and mycobacterium activity.

It is produced by the strain of Streptomyces fungicidicus. It has anti-gram-positive bacteria and mycobacterium activity.

It is produced by the strain of Fusarium orthoceras var. enniatinum. It has insecticidal and antifungal activity.

It is produced by the strain of Streptomyces griseus. It has activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and it also has antibacterial activity of phage.

It is produced by the strain of Streptomyces candidus var. entrosttaticus WS-8095, Str. viridochromogenes M-127. It has the activity of anti-gram-positive bacteria and negative bacteria, has the synergistic effect with streptomycin and chloramphenicol, and has the effect of weeding and affecting the metabolism of isoleucine.

It is produced by the strain of Semisynthetic broad-spectrum penicillin. Its antibacterial spectrum, antibacterial activity, pharmacokinetic properties and curative effect are similar to Ampicillin.

It is produced by the strain of Streptomyces gilvotanareus, Str. anandii. It has anti-gram-positive bacteria, negative bacteria, fungal activity and can inhibit sarcoma 180 and P388 leukemia cells.

It is produced by the strain of Streptomyces gilvotanareus, Str. anandii. It has anti-gram-positive bacterial activity and can inhibit sarcoma 180 and P388 leukemia cells.

It is produced by the strain of Penicillum gladioli. It has the antifungal activity of Absidia glauca Hagem, garlic spores, Byssochlamys fulva, Trichophyton mentagrophytes, Corpuscular falciparum.

It is produced by the strain of Gliocladium fimbriatum, Trichoderma lignorum, Penicillum cineroscens. It has the activity of anti-gram positive bacterium, negative bacterium, fusarium oxysporum, endosporium, ringworm fungus and other fungi, and has the effect of inhibiting poliovirus.

Glucopiericidin A is a natural piericidin compound obtained from a marine-derived Streptomyces strain. Glucopiericidin A serves as a glucose transporter (GLUT) chemical probe and suppresses glycolysis. Glucopiericidin A inhibits ATP-dependent filopodia protrusion with Piericidin A (PA; HY-114936) and has no effect alone. Glucopiericidin A induces cell apoptosis through reducing the reactive oxygen species (ROS) level by increasing PRDX1 and exhibits potent antitumor efficacy in ACHN mice xenografts.

It is produced by the strain of Streptomyces kanamyceticus A-4-6. It's an aminoglycoside antibiotic. It has anti-gram positive bacteria and negative bacteria activity.

It is produced by the strain of Basidiomycetes sp. It is a glycoside antibiotic, and has anti-gram-positive bacterial activity.

It is produced by the strain of Bacillus brevis. It is a family of linear pentadecapeptides isolated from bacillus brevis, and it is a complex of six closely related analogues A1, A2, B1, B2, C1 and C2 where A1 and A2 are the dominant components. It acts by forming channels in cell membranes causing ion leakage, and is an essential bioprobe for understanding the nature of the cell membranes.

It is produced by the strain of Bacillus brevis. It mainly has anti-gram-positive bacterial activity, and also has effects on Naisseria. LD50 is 0.017 mg/kg (mice, intravenous injection).